Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Pharmacological Research|February 10, 2026
ZBTB16 Controls the Onset of Clostridium difficile Colitis through the Pyrin InflammasomeShuhui Li, Jingjing He, Huxidanmu Tuoheniyazi, et al.
Clinical Immunology (Orlando, Fla.)|November 11, 2009
Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent mannerXiang-Liang Yuan, Lei Chen, Mei-Xing Li, et al.
Human Mutation|July 24, 2010
Genetic modulation of TLR8 response following bacterial phagocytosisMichael P Gantier, Aaron T Irving, Maria Kaparakis-Liaskos, et al.
Frontiers in Immunology|May 15, 2023
Identification of calcium and integrin-binding protein 1 as a reprogrammed glucose metabolism mediator to restrict immune cell infiltration in the stromal compartment of pancreatic ductal adenocarcinomaJunrui Ma, Yue Song, Tongtao Zhuang, et al.
Theranostics|March 7, 2018
GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascadeMingo Ming-Ho Yung, Hermit Wai-Man Tang, Patty Chun-Hui Cai, et al.
Nature Communications|April 14, 2015
The acetyltransferase HAT1 moderates the NF-κB response by regulating the transcription factor PLZFAnthony J Sadler, Bandar A Suliman, Liang Yu, et al.
Nucleic Acids Research|June 12, 2012
A miR-19 regulon that controls NF-κB signalingMichael P Gantier, H James Stunden, Claire E McCoy, et al.
Oncoimmunology|June 7, 2018
PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markersLe Ying, Feng Yan, Qiaohong Meng, et al.
Theranostics|January 2, 2018
Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathwaysKangmei Chen, Michelle Xin Liu, Celia Sze-Ling Mak, et al.
Experimental Hematology & Oncology|August 28, 2024
Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironmentHuogang Wang, Mingo Mh Yung, Yang Xuan, et al.
Pageof 9